AAAAAA

   
Results: 1-8 |
Results: 8
OPTIMAL THERAPY OF MALIGNANT PLEURAL EFFUSIONS - REPORT OF A RANDOMIZED TRIAL OF BLEOMYCIN, TETRACYCLINE, AND TALC AND A METAANALYSIS
Authors: LYNCH TJ KALISH L MENTZER SJ DECAMP M STRAUSS G SUGARBAKER DJ
Citation: Tj. Lynch et al., OPTIMAL THERAPY OF MALIGNANT PLEURAL EFFUSIONS - REPORT OF A RANDOMIZED TRIAL OF BLEOMYCIN, TETRACYCLINE, AND TALC AND A METAANALYSIS, International journal of oncology, 8(1), 1996, pp. 183-190
SEQUENTIAL PHENOTYPING OF MYELOMA PATIENTS ON CHEMOTHERAPY - PERSISTENCE OF ACTIVATED T-CELLS AND NATURAL-KILLER-CELLS
Authors: KAY NE OKEN MM KYLE R VANNESS B KALISH L LEONG T GREIPP P
Citation: Ne. Kay et al., SEQUENTIAL PHENOTYPING OF MYELOMA PATIENTS ON CHEMOTHERAPY - PERSISTENCE OF ACTIVATED T-CELLS AND NATURAL-KILLER-CELLS, Leukemia & lymphoma, 16(3-4), 1995, pp. 351-354
AN AGGRESSIVE HIGH-DOSE CYCLOPHOSPHAMIDE AND PREDNISONE REGIMEN FOR ADVANCED MULTIPLE-MYELOMA
Authors: LENHARD RE DANIELS MJ OKEN MM GLICK H ETTINGER DS KALISH L OCONNELL MJ
Citation: Re. Lenhard et al., AN AGGRESSIVE HIGH-DOSE CYCLOPHOSPHAMIDE AND PREDNISONE REGIMEN FOR ADVANCED MULTIPLE-MYELOMA, Leukemia & lymphoma, 13(5-6), 1994, pp. 485-489
PHASE-II STUDY OF TOPOTECAN IN METASTATIC NON-SMALL-CELL LUNG-CANCER
Authors: LYNCH TJ KALISH L STRAUSS G ELIAS A SKARIN A SHULMAN LN POSNER M FREI E
Citation: Tj. Lynch et al., PHASE-II STUDY OF TOPOTECAN IN METASTATIC NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 12(2), 1994, pp. 347-352
COMPARISON OF 3 COMMONLY USED PEAK FLOW METERS - ARE THEY INTERCHANGEABLE
Authors: KALISH L ROBLEY VL MEADOR G BLAISS M
Citation: L. Kalish et al., COMPARISON OF 3 COMMONLY USED PEAK FLOW METERS - ARE THEY INTERCHANGEABLE, Journal of allergy and clinical immunology, 93(1), 1994, pp. 169-169
VACCINATION PRACTICES AND RESPONSE TO BOOSTING AMONG CHILDREN AND ADOLESCENTS ENROLLED IN THE HEMOPHILIA GROWTH AND DEVELOPMENT STUDY (HGDS)
Authors: HILGARTNER M EVAN B MAEDER M DRAKE J HAWK S HOOTS WK JASON J KALISH L PATTISHALL E SHAPIRO A WARRIER I
Citation: M. Hilgartner et al., VACCINATION PRACTICES AND RESPONSE TO BOOSTING AMONG CHILDREN AND ADOLESCENTS ENROLLED IN THE HEMOPHILIA GROWTH AND DEVELOPMENT STUDY (HGDS), Pediatric research, 35(4), 1994, pp. 10000161-10000161
EFFECT OF RECOMBINANT HUMAN INTERLEUKIN-3 ON HEMATOLOGICAL RECOVERY FROM CHEMOTHERAPY-INDUCED MYELOSUPPRESSION
Authors: TEPLER I ELIAS A KALISH L SHULMAN L STRAUSS G SKARIN A LYNCH T LEVITT D RESTA D DEMETRI G GAYNES L SCHNIPPER L
Citation: I. Tepler et al., EFFECT OF RECOMBINANT HUMAN INTERLEUKIN-3 ON HEMATOLOGICAL RECOVERY FROM CHEMOTHERAPY-INDUCED MYELOSUPPRESSION, British Journal of Haematology, 87(4), 1994, pp. 678-686
INDEPENDENT PROGNOSTIC VALUE FOR PLASMA-CELL LABELING INDEX (PCLI), IMMUNOFLUORESCENCE MICROSCOPY PLASMA-CELL PERCENT (IMPCP), BETA-2-MICROGLOBULIN (B2M), SOLUBLE INTERLEUKIN-6 RECEPTOR (SIL-6R), AND C-REACTIVE PROTEIN (CRP) IN MYELOMA TRIAL E9487
Authors: GREIPP PR GAILLARD JP KLEIN B OKEN MM KALISH L LEONG T KYLE RA
Citation: Pr. Greipp et al., INDEPENDENT PROGNOSTIC VALUE FOR PLASMA-CELL LABELING INDEX (PCLI), IMMUNOFLUORESCENCE MICROSCOPY PLASMA-CELL PERCENT (IMPCP), BETA-2-MICROGLOBULIN (B2M), SOLUBLE INTERLEUKIN-6 RECEPTOR (SIL-6R), AND C-REACTIVE PROTEIN (CRP) IN MYELOMA TRIAL E9487, Blood, 84(10), 1994, pp. 10000385-10000385
Risultati: 1-8 |